Skip to main content

Resmed Value Stock - Dividend - Research Selection

Resmed

ISIN: US7611521078 , WKN: 895878

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'

2026-05-12
Jim Cramer says investors are aggressively favoring AI stocks while heavily punishing companies that disappoint Wall Street.

Jim Cramer on the current market: Hated companies are over-hated, and the loved ones are over-loved

2026-05-11
'Mad Money' host Jim Cramer recaps the day's market action.

Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?

2026-05-11
Boston Scientific Corporation outlook: EP share loss vs PFA leadership, Watchman & neuromod growth, improving margins and low valuation. Click for more on BSX.

ResMed (NYSE:RMD) Could Be A Buy For Its Upcoming Dividend

2026-05-09
It looks like ResMed Inc. ( NYSE:RMD ) is about to go ex-dividend in the next four days. The ex-dividend date is...

10 Dividend Growth Stocks: May 2025

2026-05-09
Dividend growth stocks have a streak of at least 5 consecutive years of dividend increases.

Dividend Champion, Contender, And Challenger Highlights: Week Of May 10

2026-05-08
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read this week's list here.

ResMed Inc. 2026 Q3 - Results - Earnings Call Presentation

2026-05-03
2026-05-03. The following slide deck was published by ResMed Inc.

Why ResMed (RMD) Narrative Is Shifting As Analysts Reassess Growth And Valuation Assumptions

2026-05-03
ResMed’s fair value estimate has been trimmed from US$296.53 to US$288.21, a reduction of about 2.8% that signals a more cautious stance on what analysts are willing to pay for the shares. This shift lines up with recent research where some firms have cut price targets by US$5 to US$45, while others still see room to build exposure based on their own assumptions. As you read on, you will see how to interpret these mixed signals and keep track of how the story around ResMed is...

Top 50 High-Quality Dividend Growth Stocks For May 2026

2026-05-02
Track 50 dividend growth stocks with forward return estimates (10%+), FCF-based value flags, and entry ideas for long-term total return—read now.

2 Cash-Heavy Stocks with Exciting Potential and 1 We Turn Down

2026-05-02
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.